Exogenous Volatile Organic Compound (EVOC®) Breath Testing Maximizes Classification Performance for Subjects with Cirrhosis and Reveals Signs of Portal Hypertension

Thumbnail Image

Files

143.pdf (4.44 MB)

Date

2023-11-01

Document type

journal article

Collections

Investigación
Total downloads30
Total views2
Bibliographic managers

Authors

Ferrandino, Giuseppe, Ricciardi, Federico, Murgia, Antonio, Banda, Iris, Manhota, Menisha, Ahmed, Yusuf, Sweeney, Kelly, Nicholson-Scott, Louise, McConville, Lucinda, Gandelman, Olga, Allsworth, Max, Boyle, Billy, Smolinska, Agnieszka, Ginesta Frings, Carmen A., Contreras, Jorge, Asenjo-Lobos, Claudia, Barrientos, Viviana, Clavo, Nataly, Novoa, Angela, Riviotta, Amy, Jerez, Melissa, Mendez, Luis

Publisher

MDPI AG

URI

https://repositorio.udla.cl/handle/udla/1480

DOI

https://doi.org/10.3390/biomedicines11112957

Keywords

breath biopsy, volatile organic compounds, functional diagnostics, non-invasive, MELD

Citation

Biomedicines, 11(11), 2957. https://doi.org/10.3390/biomedicines11112957

Abstract

Background: Cirrhosis detection in primary care relies on low-performing biomarkers. Consequently, up to 75% of subjects with cirrhosis receive their first diagnosis with decompensation when causal tr...

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Creative Commons Attribution 4.0 International
Except where otherwised noted, this item's license is described as Creative Commons Attribution 4.0 International
Usage statistics
01345
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26